Overview

Antiarrhythmics Versus Implantable Defibrillators (AVID)

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated from sudden cardiac death who are otherwise at very high risk of mortality from arrhythmic causes.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Amiodarone
Sotalol
Criteria
Men & women with VF, VT with syncope, or VT without syncope, but with ejection fraction
less than or equal to .40 & systolic blood pressure less than 80 mm Hg, chest pain , or
near syncope.